Free meds and tailored education may cut heart risks in Low-Income seniors

NCT ID NCT02579655

Completed Disease control Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests two strategies in low-income seniors with chronic conditions like heart disease, diabetes, or kidney disease. One group gets free preventive medications (no copayment), and another receives personalized education on medication use and lifestyle. The goal is to see if these measures reduce deaths, heart attacks, strokes, and hospitalizations over three years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Copayment elimination and personalized education
What this could lead to: If it works, this approach could lower the risk of heart attacks, strokes, and hospitalizations in low-income seniors with chronic diseases.
What could go wrong: The study focuses on a specific group (low-income seniors in Alberta), so results may not apply to others. The interventions are behavioral and policy-based, so effects may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome coronary artery disorder Coronary Disease diabetes mellitus heart failure Hypercholesterolemia hyperlipidemia hypertensive disorder stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE CORONARY DISEASE DIABETES MELLITUS HEART FAILURE HYPERCHOLESTEROLEMIA HYPERTENSION STROKE

Contacts and locations

Show contact details

Locations

University of Calgary

Calgary, Alberta, T2N 4Z6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.